Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Voriconazole in Invasive Aspergillosis
NCT01782131Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of posaconazole in invasive aspergillosis (IA), sponsored by Merck & Co.. Started Sep 2013; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT01782131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782131.